Novartis AG (SWX:NOVN)
124.28
-0.02 (-0.02%)
Jul 10, 2026, 5:30 PM CET
Novartis AG Employees
Novartis AG had 75,267 employees as of December 31, 2025. The number of employees decreased by 616 or -0.81% compared to the previous year.
Employees
75,267
Change (1Y)
-616
Growth (1Y)
-0.81%
Revenue / Employee
602.95K CHF
Profits / Employee
144.23K CHF
Market Cap
227.50B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 75,267 | -616 | -0.81% |
| Dec 31, 2024 | 75,883 | -174 | -0.23% |
| Dec 31, 2023 | 76,057 | -25,646 | -25.22% |
| Jun 30, 2023 | 103,000 | -5,000 | -4.63% |
| Mar 31, 2023 | 103,000 | -7,000 | -6.36% |
| Dec 31, 2022 | 101,703 | -2,620 | -2.51% |
| Sep 30, 2022 | 108,000 | 0 | - |
| Jun 30, 2022 | 108,000 | -1,000 | -0.92% |
| Mar 31, 2022 | 110,000 | 0 | - |
| Dec 31, 2021 | 104,323 | -1,471 | -1.39% |
| Sep 30, 2021 | 108,000 | -2,000 | -1.82% |
| Jun 30, 2021 | 109,000 | -1,000 | -0.91% |
| Mar 31, 2021 | 110,000 | 1,000 | 0.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Roche Holding AG | 103,249 |
| Alcon | 25,000 |
| Sandoz Group AG | 22,356 |
| Lonza Group AG | 20,000 |
| Sonova Holding AG | 18,590 |
| Straumann Holding AG | 11,821 |
| Galenica AG | 8,427 |
| Galderma Group AG | 7,676 |
Novartis AG News
- 3 days ago - Novartis vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026? - The Motley Fool
- 4 days ago - The Market Just Got Shaken—These 3 ETFs May Come Out Stronger - MarketBeat
- 6 days ago - Novartis to Acquire Myricx Bio for $1.5B to Boost Cancer Drugs; NVS Stock Falls - TipRanks
- 6 days ago - Novartis agrees to acquire Myricx Bio for up to $1.5B - TheFly
- 6 days ago - Novartis to acquire Myricx Bio for $1.1B upfront - TheFly
- 6 days ago - Novartis to Buy Myricx Bio for Up to $1.5 Billion - WSJ
- 6 days ago - Novartis to acquire UK-based Myricx Bio for up to $1.5 billion - Reuters
- 10 days ago - Novartis receives EC approval for Itvisma for spinal muscular atrophy - TheFly